Bortezomib will improve the level or result of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Increased flibanserin adverse results may perhaps occur if coadministered with many weak CYP3A4 inhibitors. Unlock 38% extra drug discovery time and remove determination-generating doubts using this type of a single-cease guidebook to top https://samuelh555wit9.wikiconversation.com/user